Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers

被引:196
作者
Horne, W. Seth [1 ]
Johnson, Lisa M. [1 ]
Ketas, Thomas J. [2 ]
Klasse, Per Johan [2 ]
Lu, Min [3 ]
Moore, John P. [2 ]
Gellman, Samuel H. [1 ]
机构
[1] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA
[2] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
alpha/beta-peptides; HIV; protein folding; protein-protein interactions; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1; ENTRY; FUSION INHIBITOR; ENVELOPE GLYCOPROTEIN; BH3-RECOGNITION CLEFT; ATOMIC-STRUCTURE; MEDIATED FUSION; MEMBRANE-FUSION; HELIX MIMICRY; COILED-COIL;
D O I
10.1073/pnas.0902663106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Unnatural oligomers that can mimic protein surfaces offer a potentially useful strategy for blocking biomedically important protein-protein interactions. Here we evaluate an approach based on combining alpha- and beta-amino acid residues in the context of a polypeptide sequence from the HIV protein gp41, which represents an excellent testbed because of the wealth of available structural and biological information. We show that alpha/beta-peptides can mimic structural and functional properties of a critical gp41 subunit. Physical studies in solution, crystallographic data, and results from cell-fusion and virus-infectivity assays collectively indicate that the gp41-mimetic alpha/beta-peptides effectively block HIV-cell fusion via a mechanism comparable to that of gp41-derived alpha-peptides. An optimized alpha/beta-peptide is far less susceptible to proteolytic degradation than is an analogous alpha-peptide. Our findings show how a two-stage design approach, in which sequence-based alpha ->beta replacements are followed by site-specific backbone rigidification, can lead to physical and biological mimicry of a natural biorecognition process.
引用
收藏
页码:14751 / 14756
页数:6
相关论文
共 50 条
[1]   Residue-based control of helix shape in beta-peptide oligomers [J].
Appella, DH ;
Christianson, LA ;
Klein, DA ;
Powell, DR ;
Huang, XL ;
Barchi, JJ ;
Gellman, SH .
NATURE, 1997, 387 (6631) :381-384
[2]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[3]   SPIN-GLASSES AND THE STATISTICAL-MECHANICS OF PROTEIN FOLDING [J].
BRYNGELSON, JD ;
WOLYNES, PG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7524-7528
[4]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[5]   Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target [J].
Chan, DC ;
Chutkowski, CT ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15613-15617
[6]   De novo design of a monomeric helical β-peptide stabilized by electrostatic interactions [J].
Cheng, RP ;
DeGrado, WF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (21) :5162-5163
[7]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[8]   Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor [J].
Deng, Yiqun ;
Zheng, Qi ;
Ketas, Thomas J. ;
Moore, John P. ;
Lu, Min .
BIOCHEMISTRY, 2007, 46 (14) :4360-4369
[9]   Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus [J].
Dwyer, John J. ;
Wilson, Karen L. ;
Davison, Donna K. ;
Freel, Stephanie A. ;
Seedorff, Jennifer E. ;
Wring, Stephen A. ;
Tvermoes, Nicolai A. ;
Matthews, Thomas J. ;
Greenberg, Michael L. ;
Delmedico, Mary K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (31) :12772-12777
[10]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115